This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. shed 5.8% to $1.63 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.0% to 42,001.76 and the NASDAQ Composite Index falling 0.1% to 17,299.29.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 88.9% short of its 52-week high of $14.75, which the company reached on April 1st.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 1.3% to $165.84, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.52% to $25.34.
Trading volume totaled 991,703, compared to the 50-day average of 730,483.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 31, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。